Short-term Treatment Satisfaction in Hidradenitis Suppurativa Patients Initiated on Cosentyx in Routine Clinical Practice in Saudi Arabia

Clinical trial NCT06785779 · RECRUITING

Trial details

NCT number: NCT06785779
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Study type: OBSERVATIONAL

Hidradenitis Suppurativa (HS)

Start date: 2025-03-10
Primary completion: 2026-09-30
Enrollment: 77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.